What CARGO Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks | Aug 19 | Disposition to Issuer · D | −63,436 | $4.38 | −$278K | 0 |
| Radhakrishnan Anup | See Remarks | Aug 18 | Tender Offer · U | −57,345 | $4.38 | −$251K | 63,436 |
| Radhakrishnan Anup | See Remarks | Jul 02 | Open-market sale · S | −1,632 | $4.18 | −$6.82K | 120,781 |
| Radhakrishnan Anup | See Remarks | May 14 | Open-market sale · S | −27,404 | $3.84 | −$105K | 122,413 |
| Radhakrishnan Anup | See Remarks | May 12 | Grant / award · A | +72,500 | — | — | 149,817 |
| Radhakrishnan Anup | See Remarks | Apr 03 | Open-market sale · S | −1,629 | $4.00 | −$6.52K | 77,317 |
| Gadam Shishir | Chief Technical Officer | Mar 14 | Grant / award · A | +60,000 | — | — | 89,480 |
| Laport Ginna | Chief Medical Officer | Mar 14 | Grant / award · A | +50,000 | — | — | 50,000 |
| Radhakrishnan Anup | See Remarks | Mar 14 | Grant / award · A | +72,500 | — | — | 78,946 |
| Chapman Gina | President & CEO | Mar 14 | Grant / award · A | +200,000 | — | — | 303,905 |
| Chapman Gina | President & CEO | Sep 19 | Open-market sale · S | −2,975 | $25.03 | −$74.5K | 103,905 |
| Chapman Gina | President & CEO | Sep 19 | Exercise / conversion · M | +2,975 | $5.03 | +$15K | 106,880 |
| Radhakrishnan Anup | Chief Financial Officer | Sep 18 | Open-market sale · S | −1,600 | $25.28 | −$40.5K | 6,446 |
| Radhakrishnan Anup | Chief Financial Officer | Sep 18 | Exercise / conversion · M | +1,600 | $5.03 | +$8.05K | 8,046 |
| Chapman Gina | President & CEO | Sep 18 | Open-market sale · S | −7,166 | $25.09 | −$180K | 103,905 |
| Chapman Gina | President & CEO | Sep 18 | Exercise / conversion · M | +7,166 | $5.03 | +$36K | 111,071 |
| Samsara BioCapital GP, Llc | 10% owner | May 30 | Open-market buy · P | +294,000 | $17.00 | +$5M | 4,415,689 |
| Rtw INVESTMENTS, Lp | 10% owner | Jan 12 | Other Transaction · J | −1,842,499 | — | — | 5,175,832 |
| Perceptive Advisors Llc | Insider | Nov 14 | Open-market buy · P | +333,333 | $15.00 | +$5M | 333,333 |
| Perceptive Advisors Llc | Insider | Nov 14 | Open-market buy · P | +333,333 | $15.00 | +$5M | 2,912,835 |
Loading...